Guerbet S.A.
Guerbet S.A. (GUERF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
guerf · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Guerbet S.A. (GUERF) measures how much investors pay for each dollar of the company's trailing earnings. GUERF's current PE ratio of N/A is calculated by dividing its stock price of $22.25 by its TTM earnings per share of -$8.57.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2005 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%32.5x
MedianQ3 · 75%130.4x
Max
At N/A, GUERF's current P/E is lower than in 0% of its annual fiscal year readings over the past 19 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Guerbet S.A.You GUERF | $281M | N/A | — | -$8.57 |
 biote Corp. BTMD | $105M | 3.01x | -83.4% | $0.86 |
 NIOX Group Plc CSSPF | $274M | 40.40x | +123.6% | $0.02 |
 Dialogue Health Technologies Inc. DLHTF | $255M | N/A | — | -$0.39 |
 Hamilton Thorne Ltd. HTLZF | $245M | N/A | — | -$0.00 |
 Newron Pharmaceuticals S.p.A. NWPHF | $416M | 10.81x | -40.2% | $0.85 |
 Opsens Inc. OPSSF | $247M | N/A | — | -$0.11 |
Industry Average 3 peers with valid PE | — | 18.07x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | 16.84x | $1.28 | +58.7% | |
2023-12-31 FY2023 | 10.61x | $1.90 | — | |
2022-12-31 FY2022 | — | $-3.26 | — | |
2021-12-31 FY2021 | 13.95x | $2.59 | -57.7% | |
2020-12-31 FY2020 | 32.98x | $1.45 | +88.0% | |
2019-12-31 FY2019 | 17.55x | $2.97 | -10.1% | |
2018-12-31 FY2018 | 19.51x | $3.72 | +2.5% | |
2017-12-31 FY2017 | 19.03x | $3.69 | -44.7% | |
2016-12-31 FY2016 | 34.43x | $2.33 | +44.9% | |
2015-12-31 FY2015 | 23.76x | $3.27 | -27.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Guerbet S.A. (GUERF) measures how much investors pay for each dollar of the company's trailing earnings. GUERF's current PE ratio of N/A is calculated by dividing its stock price of $22.25 by its TTM earnings per share of -$8.57.
Frequently asked questions
GUERF pe ratio · 6 questionsGUERF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $22.25 and TTM EPS of -$8.57. Data sourced from Financial Modeling Prep via GUERF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Guerbet S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09